-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the topic of “strengthening the surging impetus of technological innovation” was once a hot search, which attracted attention and heated discussions in various industries.
Innovation is more violent" and other content with emotion
.
Technology is the primary productive force
.
The high-quality development of the industrial economy is inseparable from technological innovation.
In recent years, as the "stuck neck" problem in the field of industrial economy has become more prominent, the industry has become more aware of the importance of technological innovation
.
As an important part of the traditional manufacturing industry, the modern development of the pharmaceutical equipment industry will also embark on a new journey
.
Pharmaceutical equipment (picture source: Pharmaceutical Network) The technical problem of "stuck neck" is prominent.
Looking back at the pharmaceutical equipment industry in recent years, capable domestic enterprises have made some progress in product quality and technology, which has promoted the development of the industry
.
Among them, Chutian Technology, through long-term focus on the pursuit of core technology and innovative research and development capabilities, has invested heavily in talents and R&D, and has realized the process from technological imitation to technological innovation, and gradually broke the situation of relying on imports for medical equipment.
The products of this department are exported.
More than 40 countries and regions
.
But on the whole, the core technological challenges related to "stuck necks" are still frequently mentioned by domestic pharmaceutical companies
.
Taking the direct-coupled rotary vane pump in the field of vacuum pumps as an example, some people in the industry said, "The direct-coupled rotary vane pump has passed technically, and the price is far cheaper than foreign products, but some key technologies still need to be resolved
.
" For example, in the field of pharmaceutical analysis equipment, some pharmaceutical robots pointed out that this type of equipment has very high accuracy requirements, and the domestic technology generally has the problem of stuck necks, which needs to be overcome urgently
.
According to the industry, the current research and development of domestic pharmaceutical equipment is mainly concentrated in the low-end field, with low-level repetitive production.
In the mid-to-high-end field, the core components and key technologies of domestic pharmaceutical machines are still in the hands of imported manufacturers.
The technical problem of "stuck neck" is prominent, and it is urgent for domestic enterprises to accelerate independent research and development
.
How to overcome? From the perspective of the industry, enterprises are the mainstay of innovation.
Technological innovation should aim at the technical problems, realize technological autonomy, and control core technologies in their own hands.
.
The underlying reason why the core technology is "stuck" is that the basic theoretical research is weak and the R&D investment is insufficient
.
Basic research is equivalent to the head office of all technical issues
.
At present, China’s traditional manufacturing industry, including pharmaceutical equipment, generally has many shortcomings in basic research, such as the lack of original and influential iconic scientific and technological achievements, and also the basic software and hardware, basic components, and basic materials.
There are shortcomings in such areas
.
Therefore, it is imperative to strengthen basic theoretical research and R&D investment
.
In recent years, China's pharmaceutical machinery companies have gradually paid attention to the cornerstone role of basic research, and some original innovations are also accelerating
.
However, because most of the pharmaceutical machinery companies are small and medium-sized, they hold the operating concept of low-cost operation and low-cost investment.
They are reluctant to increase investment in R&D costs and have no courage to increase investment.
They can only use the model of imitating and imitating innovation.
Following the large pharmaceutical machinery companies, there is still a significant gap between the overall level and the powerful countries
.
At present, the more representative domestic pharmaceutical giants such as Chutian and Tofflon have increased their investment in research and development in recent years, basically maintaining the level of more than 100 million yuan per year, and their proportion of revenue is constantly increasing
.
However, compared with the investment level of foreign pharmaceutical giants, there is still a big gap
.
Lack of talents is another major shortcoming.
To break through the core technical problems of the key card neck and realize the high quality of the pharmaceutical equipment industry, it is necessary to cultivate a group of high-level talents who understand both pharmaceuticals and equipment, and possess innovative ideas.
However, the pharmaceutical machinery industry currently exists.
Problems such as inability to recruit and retain people
.
In recent years, some pharmaceutical machinery companies have been in-depth internationalization, and the demand for high-end talents has become more urgent.
They will not hesitate to spend a lot of money to release recruitment information, just to attract Wutong Phoenix
.
The industry believes that it is necessary to improve the "status" and salary of the people in the pharmaceutical industry in order to attract more young talents and inject impetus into the innovation and development of the enterprise
.
Of course, policy support is also very important.
In recent years, policies have clearly favored the pharmaceutical equipment industry.
.
Among them, in May 2019, the "Industrial Structure Adjustment Guidance Catalog (2019 Edition, Draft for Comment)" was released, which clearly encourages the development and production of high-level pharmaceutical equipment; it is also mentioned in the 14th Five-Year Plan and the 2035 Vision Target Recommendation , Deploy a number of major scientific and technological projects in key areas and key links such as high-end equipment manufacturing, strive to overcome a number of key core technologies and "stuck neck" technologies, and accelerate the localized replacement of key components
.
What is certain is that high-end will become the trend and direction of the development of the pharmaceutical equipment industry
.
Conclusion 2021 is coming to an end.
The "task list" for the new year will be opened to accelerate the modernization of domestic pharmaceutical equipment.
The task of accelerating the modernization of domestic pharmaceutical equipment is arduous: the core technology of domestic pharmaceutical equipment urgently needs to further realize independent and controllable development, and the industry needs to transform from low-end to high-end.
Upgrading, a new system supported by the application of new technologies such as artificial intelligence and intelligent manufacturing is in urgent need of construction
.
Pharmaceutical machinery companies must face challenges, set goals, continue to tackle key problems, strengthen the transformation of scientific and technological achievements, and move to a new level of high-quality development
.
Innovation is more violent" and other content with emotion
.
Technology is the primary productive force
.
The high-quality development of the industrial economy is inseparable from technological innovation.
In recent years, as the "stuck neck" problem in the field of industrial economy has become more prominent, the industry has become more aware of the importance of technological innovation
.
As an important part of the traditional manufacturing industry, the modern development of the pharmaceutical equipment industry will also embark on a new journey
.
Pharmaceutical equipment (picture source: Pharmaceutical Network) The technical problem of "stuck neck" is prominent.
Looking back at the pharmaceutical equipment industry in recent years, capable domestic enterprises have made some progress in product quality and technology, which has promoted the development of the industry
.
Among them, Chutian Technology, through long-term focus on the pursuit of core technology and innovative research and development capabilities, has invested heavily in talents and R&D, and has realized the process from technological imitation to technological innovation, and gradually broke the situation of relying on imports for medical equipment.
The products of this department are exported.
More than 40 countries and regions
.
But on the whole, the core technological challenges related to "stuck necks" are still frequently mentioned by domestic pharmaceutical companies
.
Taking the direct-coupled rotary vane pump in the field of vacuum pumps as an example, some people in the industry said, "The direct-coupled rotary vane pump has passed technically, and the price is far cheaper than foreign products, but some key technologies still need to be resolved
.
" For example, in the field of pharmaceutical analysis equipment, some pharmaceutical robots pointed out that this type of equipment has very high accuracy requirements, and the domestic technology generally has the problem of stuck necks, which needs to be overcome urgently
.
According to the industry, the current research and development of domestic pharmaceutical equipment is mainly concentrated in the low-end field, with low-level repetitive production.
In the mid-to-high-end field, the core components and key technologies of domestic pharmaceutical machines are still in the hands of imported manufacturers.
The technical problem of "stuck neck" is prominent, and it is urgent for domestic enterprises to accelerate independent research and development
.
How to overcome? From the perspective of the industry, enterprises are the mainstay of innovation.
Technological innovation should aim at the technical problems, realize technological autonomy, and control core technologies in their own hands.
.
The underlying reason why the core technology is "stuck" is that the basic theoretical research is weak and the R&D investment is insufficient
.
Basic research is equivalent to the head office of all technical issues
.
At present, China’s traditional manufacturing industry, including pharmaceutical equipment, generally has many shortcomings in basic research, such as the lack of original and influential iconic scientific and technological achievements, and also the basic software and hardware, basic components, and basic materials.
There are shortcomings in such areas
.
Therefore, it is imperative to strengthen basic theoretical research and R&D investment
.
In recent years, China's pharmaceutical machinery companies have gradually paid attention to the cornerstone role of basic research, and some original innovations are also accelerating
.
However, because most of the pharmaceutical machinery companies are small and medium-sized, they hold the operating concept of low-cost operation and low-cost investment.
They are reluctant to increase investment in R&D costs and have no courage to increase investment.
They can only use the model of imitating and imitating innovation.
Following the large pharmaceutical machinery companies, there is still a significant gap between the overall level and the powerful countries
.
At present, the more representative domestic pharmaceutical giants such as Chutian and Tofflon have increased their investment in research and development in recent years, basically maintaining the level of more than 100 million yuan per year, and their proportion of revenue is constantly increasing
.
However, compared with the investment level of foreign pharmaceutical giants, there is still a big gap
.
Lack of talents is another major shortcoming.
To break through the core technical problems of the key card neck and realize the high quality of the pharmaceutical equipment industry, it is necessary to cultivate a group of high-level talents who understand both pharmaceuticals and equipment, and possess innovative ideas.
However, the pharmaceutical machinery industry currently exists.
Problems such as inability to recruit and retain people
.
In recent years, some pharmaceutical machinery companies have been in-depth internationalization, and the demand for high-end talents has become more urgent.
They will not hesitate to spend a lot of money to release recruitment information, just to attract Wutong Phoenix
.
The industry believes that it is necessary to improve the "status" and salary of the people in the pharmaceutical industry in order to attract more young talents and inject impetus into the innovation and development of the enterprise
.
Of course, policy support is also very important.
In recent years, policies have clearly favored the pharmaceutical equipment industry.
.
Among them, in May 2019, the "Industrial Structure Adjustment Guidance Catalog (2019 Edition, Draft for Comment)" was released, which clearly encourages the development and production of high-level pharmaceutical equipment; it is also mentioned in the 14th Five-Year Plan and the 2035 Vision Target Recommendation , Deploy a number of major scientific and technological projects in key areas and key links such as high-end equipment manufacturing, strive to overcome a number of key core technologies and "stuck neck" technologies, and accelerate the localized replacement of key components
.
What is certain is that high-end will become the trend and direction of the development of the pharmaceutical equipment industry
.
Conclusion 2021 is coming to an end.
The "task list" for the new year will be opened to accelerate the modernization of domestic pharmaceutical equipment.
The task of accelerating the modernization of domestic pharmaceutical equipment is arduous: the core technology of domestic pharmaceutical equipment urgently needs to further realize independent and controllable development, and the industry needs to transform from low-end to high-end.
Upgrading, a new system supported by the application of new technologies such as artificial intelligence and intelligent manufacturing is in urgent need of construction
.
Pharmaceutical machinery companies must face challenges, set goals, continue to tackle key problems, strengthen the transformation of scientific and technological achievements, and move to a new level of high-quality development
.